2025-04-12_00000116
|
ligand
|
9BBX
SARS-CoV-2 Mpro in complex with compound 6l inhibitor;
X-ray diffraction 1.80Å
Protein #1
306 residues (100% resolved)
Raw Sequence ...
SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ
Canonical Sequence ...
SGFRKMAFPSGKVEGCMVQVTCGTTTLNGLWLDDVVYCPRHVICTSEDMLNPNYEDLLIRKSNHNFLVQAGNVQLRVIGHSMQNCVLKLKVDTANPKTPKYKFVRIQPGQTFSVLACYNGSPSGVYQCAMRPNFTIKGSFLNGSCGSVGFNIDYDCVSFCYMHHMELPTGVHAGTDLEGNFYGPFVDRQTAQAAGTDTTITVNVLAWLYAAVINGDRWFLNRFTTTLNDFNLVAMKYNYEPLTQDHVDILGPLSAQTGIAVLDMCASLKELLQNGMNGRTILGSALLEDEFTPFDVVRQCSGVTFQ
Non polymer #2
A1ALN
InChI=1S/C28H34N6O3/c1-17(2)12-24(28(37)32-23(15-29)14-21-10-11-30-26(21)35)33-27(36)19-6-4-18(5-7-19)20-8-9-25-22(13-20)16-31-34(25)3/h4-9,13,15-17,21,23-24,29H,10-12,14H2,1-3H3,(H,30,35)(H,32,37)(H,33,36)/b29-15+/t21-,23-,24-/m0/s1
InChI=1S/C28H34N6O3/c1-17(2)12-24(28(37)32-23(15-29)14-21-10-11-30-26(21)35)33-27(36)19-6-4-18(5-7-19)20-8-9-25-22(13-20)16-31-34(25)3/h4-9,13,15-17,21,23-24,29H,10-12,14H2,1-3H3,(H,30,35)(H,32,37)(H,33,36)/b29-15+/t21-,23-,24-/m0/s1
SMILES: CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=N)NC(=O)c2ccc(cc2)c3ccc4c(c3)cnn4C
CC(C)C[C@@H](C(=O)N[C@@H](C[C@@H]1CCNC1=O)C=N)NC(=O)c2ccc(cc2)c3ccc4c(c3)cnn4C
Biounit #1
monomer
Download coordinates
Tube
Model
Reference
100%